ARCHIVES

Why Four? NCI Official Challenged To Explain Rational For Proposed Number Of Groups

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Oppose Group’s Tamoxifen Trial, But Okay The Idea

July 6, 1990

Iressa May Benefit Some Breast Cancer, Studies Find

December 27, 2002

‘Be Careful We’re Not Fighting Old Battles’ On Study Section Issue

September 20, 1991

Cancer Incidence Rates For Recent Years Too Optimistic, NCI Researchers Find

October 25, 2002

ACCC Workshop Set for Sept; Planning Grant Okd

June 6, 1975

In Brief: Lee Helman To Head NCI Pediatric Branch; HHS to Hear From Academic Health Centers

August 22, 1997